Member Info for Masiu2017

Part of the group dev manager's job role is 'rapid recruitment' indicates substantial growth is upon us and additional vacancys will become avaliable in due course on top of the 4 new roles.

https://twitter.com/deepmattergroup/status/1329394146558271488?s=19

Hopefully Karen help with this.

DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, is pleased to announce two appointments to the Board, effective on 1 November 2020. Karen Bach will join as Non-Executive Chair and Fraser Benson will join as Chief Financial Officer.



Karen Bach brings significant public and private technology expertise, particularly focused on helping young technology businesses deliver on their growth potential, with an understanding of the life sciences through her Non-Executive Directorship at Datapharm Ltd. This is coupled with a strong financial background, having held the CFO role at growing technology businesses; IXEurope Plc, ACS Plc and Kewill Plc; and with blue chip multi-nationals including EDS France, MCI WorldCom, General Motors and Ernst & Young. Karen is currently Chair of Amino Technologies Plc and Consult Red Ltd and Non-Executive Director of Escape Hunt Plc. As well as advising businesses, Karen is a member of the 30% Club, which supports boards to appoint more female directors and increase the pipeline of upcoming female talent at board and senior management levels.

Bit harsh that, forums are for debate, questions & reasearch. This company isn't exactly the most straight forward. He's probably asking the question to confirm his reasearch on a possible investment in the business

Cronin is a goat, helping the US and UK goverments during lock down, they are into everything........ Tick tock

https://youtu.be/zEjGxnqmQPg

YouTube link to CNBC article

damage already done imo - 90% down

Mr. Benamor's offer to buy 29% of the Company's shares at up to 20p per share may never materialise as it is conditional on a number of third party actions, but significant damage will have been done to the Company if the Resolutions are passed:

Reasonable chunks being bought @2.5

Really let this go... My eyes are on tomorrows close and possible newsflow beyond that

Speak next week

Totally agree, down to 8p

2rein

When you say profits improve, company has 85m net profit with a 160m mcap & no debt

What am I missing this looks cheap ?

Are they paying a divi as I cant seem to find an announcement

Alt

We've seen a few false breakouts over the past few months

17m mcap

The right rns will send this to 8p in 2 days, loads of news to Come

Gla

paid 36k
this is going one way

Can anyone explain the relevance of this? I've been opening positions over the last few weeks no problem at all.

I see 3 partners on this list, 1 could be lucky but 3! No company with a 17m mcap could partner with 3 of the world's biggest companies...... UNLESS?

https://www.statista.com/statistics/263264/top-companies-in-the-world-by-market-value/

If the city boys sniff 1 piece of positive news from one of the many collabs this will go to 100m mcap before you can hit your broker up with an order

Infochem is worth 10m on its own
Novartis to Come, placing done
Revenue 1.2m at Dec 2019.
Sells being soaked, ip & cronin increasing

What's happened.....?

Should roof up today, more news flow to come on the other 3 drills which are hopefully similar grades

Im relaxed with this one.

Unlocking the power of partnerships: 5 lessons I’ve learned so far
https://www.linkedin.com/pulse/unlocking-power-partnerships-5-lessons-ive-learned-so-bertrand-bodson

Novartis is headquartered in Basel, Switzerland and has 185 office locations across 92 countries.
Employees 103,914

That equates to a lot of licences and hardware

News should drop sooner rather than later

Considering the fall in the wider market, when the market inevitably turns I think 35-40p will be seen quite rapidly and a new base formed at those levels

Gla

Is that a sell? At what point what they get a price of 2.24 for 1.5m.....